Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque

Author： Macphee Colin H   Suckling Keith E  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.3, 2002-06, pp. : 309-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Simvastatin Reduces Expression and Activity of Lipoprotein-associated Phospholipase A2 in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits

By Qiao Z   Ren J   Chen H  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 1029-1037

Field House Publishing

Access to resources Recommend Favorite

Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease

By  

Current Pharmaceutical Design, Vol. 24, Iss. 3, 2018-04 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 4, 2011-01 ,pp. : 236-246

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target

By Macphee Colin   Benson G Martin   Shi Yi   Zalewski Andrew  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3656-3661

Bentham Science Publishers

Access to resources Recommend Favorite